标题: Some HCV news [打印本页] 作者: StephenW 时间: 2011-11-15 22:47 标题: Some HCV news
Platelet Booster Aids HCV Therapy
SAN FRANCISCO -- Patients with chronic hepatitis C virus infection and thrombocytopenia had significant improvement in virologic response when pegylated interferon alpha 2a was given with eltrombopag, results of a randomized trial showed. Milk Thistle No Help in Chronic HCV
SAN FRANCISCO -- A botanical agent used in the treatment of liver disorders had no detectable effect on hepatitis C virus disease activity in comparison with placebo in patients with previously treated chronic disease, results of a randomized trial showed. New PI Effective, Safe in HCV Trial
SAN FRANCISCO -- An investigational hepatitis C drug was safe and effective in a small randomized trial, a researcher said here. HCV Drug Effective in Patients Co-Infected With HIV
SAN FRANCISCO -- In patients with both HIV and hepatitis C virus, response rates to a direct-acting agent that targets the liver virus were high, a researcher said here. MicroRNA Drug Safe in Ongoing HCV Study
SAN FRANCISCO -- A novel hepatitis C virus drug targeting genetic material in the liver was safe and well tolerated in a small, dose-finding clinical trial, a researcher said here. Fatty Liver May Benefit from Mediterranean Diet
SAN FRANCISCO -- The so-called Mediterranean diet may be a way to treat non-alcoholic hepatic steatosis or fatty liver disease, a researcher said here. Oral HCV Combo Yields Rapid Response
SAN FRANCISCO -- A combination of two investigational antiviral drugs with different mechanisms of action against hepatitis C virus yielded quick and persistent responses in previous nonresponders without the use of pegylated interferon, a researcher said here. New HCV Drug Promising, Cuts Out Interferon
SAN FRANCISCO -- Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by -- pegylated interferon-alpha.
